MrSuccess wrote:Marc - Now we are getting somewhere ....... thanks for putting an actual name ...... to your experts. It was really unfair of you to alway's call into question ......... the validity of the work of " named " medical professionals........ with comments like ...... " I get my information from someone in some organization ..... better than yours " .
That " trump " card style ...... is bad form.
Should be interesting to gauge the reaction Dr. Hubbard has in having his work ...... called into question . Now that we know who the critics are .
These are Dr.Reich and Dr. Cortese ?
I can say with 100 % assurance that Dr.Hubbard is absolutely welcoming in having his research peer reviewed .
That is a common thread among the CCSVI medical professionals ..... starting with Dr. Zamboni ...... they welcome others to duplicate their research results .
Who can ask for more ?
Cece wrote:marcstck wrote:I was also sorry that your patient Roundtable was cut so short. It seemed like it could have gone in a lot of interesting directions…
Is that a good or bad thing?
What question would you have asked us?
Lyon wrote:Thanks for the response Marc.marcstck wrote:I've been using Dragon NaturallySpeaking for about four and half years now. It's a godsend, as my right arm and hand are about as useful as a salami.
Not that there's anything wrong with salami, mind you, I just wouldn't want to have to try to type with one…
The Dragon software does so well or you use it so well that I'd never have guessed that voice recognition software had progressed so far since I last tried it......10? or so years ago.
marcstck wrote:The contention that many of the symptoms alleviated by CCSVI treatment are not quantifiable is also interesting, and of course somewhat problematic. While fatigue might not be quantifiable, certainly cognitive functioning is, if pre-and post-neuropsych testing could be done on potential CCSVI treatment candidates.
Jpn J Pharmacol. 1998 Apr;76(4):349-67.
Toda N, Okamura T.
SourceDepartment of Pharmacology, Shiga University of Medical Science, Seta, Ohtsu, Japan.
The vascular tone, vascular resistance and blood flow in the brain are regulated by neural and humoral factors in quite a different way from those of peripheral organs and tissues. In contrast to the dominant vasoconstrictor control in the periphery, the intracranial vascular tone is predominantly influenced by vasodilator mediators over vasoconstrictor ones. Recent studies have revealed that nitroxidergic vasodilator nerve and endothelium-derived hyperpolarizing factor (EDHF) or K+ channel opening substance appear to play important roles in the regulation of cerebral arterial and arteriolar tone in primate and subprimate mammals, in addition to the accepted information concerning the crucial contribution of endothelium-derived relaxing factor (EDRF) or nitric oxide (NO), polypeptides, prostanoids, etc. This article summarizes characteristic properties of vasodilator factors in controlling the cerebral arterial and arteriolar tone that undoubtedly contribute to circulatory homeostasis. The content includes vasodilator nerve, endogenous vasodilator substances, and vasodilator interventions such as hypoxia, hypercapnia and hyperosmolarity.
Users browsing this forum: ALA